A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors
Clinical trial NCT04914286 · COMPLETED
Trial details
- NCT number
- NCT04914286
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2023-12-31
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.